Molecular pathways of neurodegeneration in Parkinson's disease.


Parkinson's disease (PD) is a complex disorder with many different causes, yet they may intersect in common pathways, raising the possibility that neuroprotective agents may have broad applicability in the treatment of PD. Current evidence suggests that mitochondrial complex I inhibition may be the central cause of sporadic PD and that derangements in… (More)


  • Blog articles referencing this paper

  • Presentations referencing similar topics